![]() A significant pipeline of joint ventures, extensions of existing relationships and acquisitions is expected to accelerate revenue growth. The combined company will be positioned as the preferred in-home healthcare partner to current and potential hospital joint venture partners as well as referral sources. ![]() Accelerated Growth: The creation of a comprehensive in-home healthcare solution with home health, hospice and personal care services sets the stage for new channels of organic growth throughout the existing footprint.The combined company is well-positioned to lead the industry’s transition to value-based reimbursement and highly coordinated care. Industry Leadership: Creates the leading in-home healthcare company in the United States, with a large, national footprint and diversified lines of service as well as Centers for Medicare & Medicaid Services (CMS) Star ratings that outpace the industry.The combined company will have 781 locations in 36 states with more than 31,000 employees and revenue of $1.8 billion and Adjusted EBITDA of approximately $145 million for the trailing 12-month period ended September 30, 2017. The merger will create a nationwide provider of in-home healthcare services with a long track record of successfully partnering with hospitals and health systems led by the most experienced management team steeped in home health. (NASDAQ:AFAM) announced today that they have agreed to combine in an all-stock merger of equals transaction pursuant to a definitive merger agreement unanimously approved by the Boards of Directors of each company. 16, 2017 (GLOBE NEWSWIRE) - LHC Group, Inc. Multi-channel growth opportunities accelerate organic growth, expand joint venture relationships and extend service lines.Well-capitalized balance sheet for continued growth through acquisitions.Diversification of services and expansion of geographic footprint creates in-home healthcare provider and joint venture partner of choice for leading hospitals and health systems.$25 million in run-rate cost synergies identified.Immediately accretive for the shareholders of each company.Well-positioned to lead the transition to value-based reimbursement through the highest quality and patient satisfaction. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |